Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Recently, Evecxia completed a Phase 1 SAD/MAD trial for EVX-101 and a Phase 1 SAD trial for EVX-301 both in healthy volunteers treated with a first-line antidepressant (escitalopram, an SSRI)
While promising in animal studies, human trials are limited, and it is not a standard medical treatment
It is especially common for drugs that require multiple doses drawn from the same vial
The information here has been written in reference to Olympias NAD+ 100mg/mL injection only
US$ 22.12
US$ 23.60
US$ 22.27
US$ 29.72
